TAS2R38 and colorectal carcinoma: Subjects with the TAS2R38 PAV/* diplotype and the CA6 variant G allele were less likely to have CRC (adjusted OR = 0.71, 95% CI: 0.53–0.94), compared to those with the reference PAV/* and AA genotype.